Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper

Ernst R. Tamm; Leopold Schmetterer; Franz Grehn

doi:10.1007/s00441-013-1637-3

Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper

Ernst R. Tamm^*, Leopold Schmetterer, Franz Grehn

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

13 Citations (Scopus)

Abstract

Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.

Original language	English
Pages (from-to)	347-354
Number of pages	8
Journal	Cell and Tissue Research
Volume	353
Issue number	2
DOIs	https://doi.org/10.1007/s00441-013-1637-3
Publication status	Published - Aug 2013
Externally published	Yes

ASJC Scopus Subject Areas

Pathology and Forensic Medicine
Histology
Cell Biology

Keywords

Glaucoma
Neuroprotection
Retina
Retinal ganglion cells
Therapy

Access to Document

10.1007/s00441-013-1637-3

Cite this

@article{7a0550b74f3f45a18922d288e55f9077,

title = "Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper",

abstract = "Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.",

keywords = "Glaucoma, Neuroprotection, Retina, Retinal ganglion cells, Therapy",

author = "Tamm, {Ernst R.} and Leopold Schmetterer and Franz Grehn",

year = "2013",

month = aug,

doi = "10.1007/s00441-013-1637-3",

language = "English",

volume = "353",

pages = "347--354",

journal = "Cell and Tissue Research",

issn = "0302-766X",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Status and perspectives of neuroprotective therapies in glaucoma

T2 - The European Glaucoma Society White Paper

AU - Tamm, Ernst R.

AU - Schmetterer, Leopold

AU - Grehn, Franz

PY - 2013/8

Y1 - 2013/8

N2 - Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.

AB - Glaucoma, a chronic progressive neuropathy and the most frequent cause of irreversible blindness worldwide, is commonly treated by medication or surgery aimed at lowering intraocular pressure. In view of the limited therapeutic options, the European Glaucoma Society (EGS) sponsored two Think Tank Meetings with the goal of assessing the current status and the overall perspectives for neuroprotective treatment strategies in glaucoma. The results of the meetings are summarized in this EGS White Paper.

KW - Glaucoma

KW - Neuroprotection

KW - Retina

KW - Retinal ganglion cells

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84880765892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880765892&partnerID=8YFLogxK

U2 - 10.1007/s00441-013-1637-3

DO - 10.1007/s00441-013-1637-3

M3 - Review article

C2 - 23712457

AN - SCOPUS:84880765892

SN - 0302-766X

VL - 353

SP - 347

EP - 354

JO - Cell and Tissue Research

JF - Cell and Tissue Research

IS - 2

ER -

Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper

Abstract

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this